April 2, 2024 — A woman’s cardiovascular risk can rise sharply after she goes through menopause, quickly catching up to ...
April 2, 2024 — Individuals with heart disease stand to gain the most from a low sodium diet but, on average, consume ...
April 2, 2024 — Medical device technology developer Concept Medical has announced it has been granted Investigational ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
April 2, 2024 — People who use e-cigarettes are significantly more likely to develop heart failure compared with those ...
April 2, 2024 — Abbott announced that the U.S. Food and Drug Administration (FDA) approved the company's first-of-its ...
April 1, 2024 — Esperion announced that the United States Food and Drug Administration (FDA) has approved broad new ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
April 1, 2024 — Roughly 25,000 Americans die each year from valvular heart disease, but researchers from Rutgers Health ...
April 1, 2024 — Sleeping fewer than seven hours is associated with a higher risk of developing high blood pressure over ...
March 29, 2024 — Young adults who were prescribed stimulant medications for attention-deficit/hyperactivity disorder ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
March 29, 2024 — V-Wave announced it will present late-breaking data from its RELIEVE-HF pivotal trial at the American ...
March 28, 2024 — Medtronic plc, a global leader in healthcare technology, announced that the United States Food and Drug ...
March 28, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
March 28, 2024 — Cleerly, the company on a mission to create a new standard of care to aid in the diagnosis of heart ...
March 27, 2024 — Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved OPSYNVI – ...
March 27, 2024 — Elixir Medical has announced it has been granted Breakthrough Device Designation by the U.S. Food and ...